CCCC icon

C4 Therapeutics
CCCC

Overview Fund Trends Analyst Outlook Journalist POV

75 hedge funds and large institutions have $743M invested in C4 Therapeutics in 2020 Q4 according to their latest regulatory filings, with 75 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

Holders
75
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
6
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$105M
2
+$80M
3
+$68.7M
4
BCLSI
Bain Capital Life Sciences Investors
Massachusetts
+$54.4M
5
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$49.4M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$105M
2
$80M
3
$68.7M
4
$54.4M
5
$49.4M
6
$45.6M
7
$40.4M
8
$37.8M
9
$29.5M
10
$22.2M
11
$18.4M
12
$15.9M
13
$15.8M
14
$15M
15
$14.6M
16
$9.96M
17
$8.9M
18
$8.25M
19
$7.57M
20
$6.63M
21
$6.27M
22
$5.74M
23
$5.61M
24
$5.51M
25
$5.47M
1
2 3